VP, Franchise Portfolio Management at Azurity Pharmaceuticals

Woburn, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Entrepreneurial mindset and drive
Cross-functional leadership and ability to drive action through others
Business acumen
Category therapeutic knowledge
Familiarity with pharmaceutical drug development, commercial processes and product lifecycles
Understanding of regulatory processes and IP evaluation
Strong criteria-based decision-making and execution capabilities
Product selection expertise, creation of TPPs and life-cycle management
Curiosity/industry network
Financial modeling, forecasting and P&L construction
Ability to take a systems approach

Responsibilities

Maintain a comprehensive subject matter expertise for the category through primary and secondary research, ad boards, market scanning, competitive intelligence and customer input
Ideate and select products to construct a funnel of candidates for development, each with a compelling and distinct TPP, subsequently driving progress through development, registration and launch
Continue to drive product enhancements and line-extensions beyond launch and plan effectively for replacement and withdrawal of commercial support at end of life
Own and drive PLM process stage-gates 1-9 at scale and speed (“cradle to grave”), convening and leading A3 Cross-functional teams; ensure stage-gate criteria are met at every stage; “push” each function to deliver effectively and to budget at each stage from development, through launch, growth and maturity; recommend discontinuations as appropriate
Develop and maintain a balanced strategic plan for the category (stage, dose-form, technology etc.), managing replacement of mature assets and growing category revenues over the long-term
Challenge business development to provide assets that supplement the internally developed portfolio
Develop external partnerships to access new technologies and otherwise enhance portfolio development

Skills

Portfolio Management

Product Lifecycle Management

Strategic Planning

Market Analysis

Data Analysis

Business Development

Cross-functional Leadership

Financial Modeling

Product Development

Franchise Management

Azurity Pharmaceuticals

Develops specialized formulations of medicines

About Azurity Pharmaceuticals

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by traditional pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Woburn, MassachusettsHeadquarters

2000Year Founded

$182.2MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Professional Development Budget

Tuition Reimbursement

Wellness Program

Risks

Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.

Integration challenges from Slayback Pharma acquisition may disrupt operations.

Reliance on FDA approvals means regulatory delays could impact product launches.

Differentiation

Azurity focuses on innovative dose forms for overlooked patient needs.

Their FDA-approved products ensure safety and efficacy in specialized formulations.

Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Upsides

Growing demand for personalized medicine aligns with Azurity's specialized dose forms.

Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.

FDA's focus on novel formulations benefits Azurity's product pipeline.

Land your dream remote job 3x faster with AI

Try Jobo Free